Mandy Wootton

10PUBLICATIONS
68CO-AUTHORS
Medical infection agents (incl. prions)BacteriologyEpidemiological methodsMedical bacteriologyGenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 09, 2026
INVICTUS II: comparison of disc diffusion and broth microdilution methods for susceptibility testing of ceftolozane/tazobactam and five comparator agents against a subset of INVICTUS I Pseudomonas aeruginosa clinical isolates.

|Sep 25, 2026
Challenges in establishing epidemiological cut-off values for the Burkholderia cepacia complex.

|Sep 08, 2026
Reconciling differences between EUCAST 'breakpoint-defining doses' and UK national antimicrobial treatment guidelines.

|Apr 20, 2026
A multicenter performance evaluation of aztreonam-avibactam gradient diffusion susceptibility testing for Enterobacterales.

|Jan 21, 2026
Assessing antimicrobial susceptibility testing guideline adherence by laboratories providing bacteriology services in Ghana: a pilot study.

Joseph Elikem Efui Acolatse, Mandy Wootton, Saviour Kwame Yevutsey

|Nov 03, 2025
Rifampicin as monotherapy for infections caused by Staphylococcus aureus: considerations for not applying 'breakpoints in brackets'.

Sara E Boyd, Mandy Wootton, Robin A Howe

Pageof 2

Frequent Collaborators

3 joint publications

Sara E Boyd

1 joint publications

R A Abbott

1 joint publications

A Cordaro

1 joint publications

B Lloyd